Top compounds associated with response to NUTM2F


Feature Type Standardized
Nominal ANOVA
mRNA GSK461364 CTRPv2 pan-cancer AAC 0.029 0.4
mRNA BEC CTRPv2 pan-cancer AAC -0.066 0.4
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.027 0.4
mRNA brivanib CTRPv2 pan-cancer AAC 0.032 0.4
mRNA ISOX CTRPv2 pan-cancer AAC -0.029 0.4
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.027 0.4
mRNA cediranib CTRPv2 pan-cancer AAC -0.049 0.4
mRNA PI-103 CTRPv2 pan-cancer AAC -0.031 0.4
mRNA BRD-K03911514 CTRPv2 pan-cancer AAC -0.047 0.4
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.032 0.4
Download CSV